🚀 Medial Secures Investment on Shark Tank India - Fueling the Future of Professional Social Networking. 🔥
✕
Login
Home
News
Messages
Startup Showcase
Trackers
Premium
Premium Content
Jobs
Notifications
Settings
Try our Valuation Calculator →
Log In
News on Medial
Bernstein Cautions On PB Fintech’s Healthcare Foray, Caps Downside At $100 Mn
Inc42
·
10m ago
Medial
- PB Fintech's stock price on the BSE fell by 1.5% to INR 1628.3 per share. - The decline in stock price followed concerns raised by Bernstein about the company's healthcare sector expansion plans. - Bernstein has expressed caution regarding the potential outcome of PB Fintech's foray into healthcare. - If PB Fintech's healthcare endeavors do not materialize as expected, Bernstein forecasts a potential downside of up to $100 Mn on the stock's price. - The stock's performance will likely be influenced by the company's success in the healthcare sector.
View Source
Related News
Policybazaar parent PB Fintech enters healthcare with new subsidiary
YourStory
·
8m ago
Medial
Policybazaar's parent company, PB Fintech Limited, has announced plans to enter the healthcare sector by setting up a subsidiary named PB Healthcare Private Limited. PB Fintech aims to address inefficiencies in the insurance ecosystem and improve trust by focusing on the lifetime value of customers. The company will invest up to $100 million in infrastructure and operational frameworks. The proposed model involves partnerships with hospitals and insurers to establish standardized procedures and reduce claims discrepancies. This move is expected to accelerate industry growth and indirectly benefit Policybazaar's market penetration. PB Fintech reported a significant increase in revenue and profits in Q2 FY25.
View Source
PB Fintech’s top two executives plan to sell 1.86% stake
Livemint
·
1y ago
Medial
Yashish Dahiya, chairman and CEO, and Alok Bansal, vice-chairman of PB Fintech, the parent company of Policybazaar, are looking to sell a combined stake of 1.86% in the company. Dahiya will sell up to 54 lakh shares, while Bansal will sell up to 29.7 lakh shares at a floor price of ₹1,258 per share. The estimated total deal value is ₹1,053 crore. The sale is managed by Morgan Stanley. This follows the exit of major shareholder Temasek Holdings earlier this year. PB Fintech recently posted strong Q4 results, with a surge in net profit and revenue.
View Source
PB Healthcare to raise Rs 1,461 Cr in seed round; no longer subsidiary of PB Fintech
Entrackr
·
3m ago
Medial
PB Healthcare Services, formerly a wholly-owned subsidiary of PB Fintech Limited, is raising Rs 1,461 crore (approximately $171 million) as part of the first tranche of its seed round. Of the total amount, Rs 539.4 crore has already been infused by PB Fintech Limited, while the remaining capital will be contributed by external investors, according to disclosures filed with the National Stock Exchange (NSE). For context, PB Fintech had earlier passed a resolution to invest up to Rs 696 crore through the purchase of equity shares or preference shares of PB Healthcare Services Private Limited in FY26. As part of the current round, it has already invested Rs 539.4 crore, with the remaining amount yet to be deployed. As per the filings, PB Fintech’s stake in PB Healthcare Services has dropped from 100% to 32.14% following the participation of external investors in the seed round. Previously a wholly-owned subsidiary, PB Healthcare has also created an ESOP pool to attract and retain key talent. The capital infusion is aimed at strengthening the company’s financial position and supporting its growth plans. “The dilution in shareholding is a strategic decision to bring in external investors and create an ESOP pool to attract and retain talent,” the company noted in its filing. Founded in January 2025, PB Healthcare Services set out with an ambitious goal of establishing hospitals with a cumulative capacity of 1,000 beds within its first year. The company plans to launch operations in the National Capital Region (NCR), with a phased expansion into other major metro cities.
View Source
PolicyBazaar parent to back healthcare push with Rs 696 Cr investment
YourStory
·
4m ago
Medial
PB Fintech, PolicyBazaar's parent company, will invest Rs 696 crore in its healthcare arm, PB Healthcare Services, acquiring up to 33.63% equity. This investment, subject to shareholder approval, will finance equity shares and CCPS in FY 2025-26. PB Healthcare plans to establish 1,000-bed hospitals starting in NCR, later expanding. The initiative focuses on long-term customer value in healthcare, partnering with hospitals and insurers to streamline operations and boost industry growth.
View Source
PB Healthcare secures $218 million from General Catalyst, PB Fintech, others
Economic Times
·
3m ago
Medial
PB Healthcare Services, a PB Fintech affiliate, secured $218 million in its first equity infusion from General Catalyst and other investors to develop a hospital chain. PB Fintech, which holds a 26% stake in the healthcare venture, contributed $62 million. The funds will build five to six 200-250 bed hospitals in the National Capital Region initially. The initiative aims to integrate healthcare and insurance while focusing on improving long-term health outcomes and patient experiences.
View Source
PB Fintech invests Rs 539 crore in healthcare arm
Economic Times
·
3m ago
Medial
PB Fintech, the parent of Policybazaar and Paisabazaar, invested Rs 539.4 crore in its health subsidiary, PB Healthcare Services, as part of a Rs 1,461.6 crore seed funding round. This investment, involving 5.39 crore Compulsory Convertible Preference Shares, will support the subsidiary's growth and financial strength. The company's stake will reduce from 100% to 32.14% due to external investor participation. The funds will also establish an Employee Stock Option Plan to retain talent.
View Source
These 4 sectors may witness turnaround in FY25, says Union AMC's Hardick Bora
Money Control
·
1y ago
Medial
Hardick Bora, Co-Head Equities at Union AMC, has a positive stance on the IT sector, believing that it may be near the end of the earnings downgrade cycle. He also highlights the automobiles, industrial/capital goods, healthcare, real estate, and PSU banks sectors as ones to watch for potential business growth and valuations. Bora expects a turnaround in sectors such as information technology, retail/QSRs, chemicals, and private banks in FY25. However, he advises caution when investing in mid-caps and small-caps, suggesting a staggered investment approach. He anticipates strong corporate earnings in FY25, but notes the risks of geopolitical tensions and slower global economic growth.
View Source
GIC bets over $100 mn on Indian healthcare company
VCCircle
·
3m ago
Medial
GIC, Singapore's sovereign wealth fund, has significantly invested over $100 million in an Indian healthcare company, which also counts Temasek, another major Singaporean state investment firm, as a key shareholder. GIC's move underscores its active investment strategy in India, especially in the healthcare sector. This collaboration highlights the increasing interest and confidence of global investors in India's burgeoning healthcare industry, aiming to capitalize on its growth potential and innovation.
View Source
HealthKois launches $300 Mn healthcare transformation fund
Entrackr
·
2m ago
Medial
HealthKois launches $300 Mn healthcare transformation fund Healthcare-focused investment firm HealthKois has launched with a target corpus of $300 million, along with a $100 million green shoe option. Spearheaded by the founding team behind HealthQuad — Charles Janssen (Managing Partner), Ajay Mahipal (Partner), and Dr. Pinak Shrikhande (Partner) — HealthKois will back early growth-stage healthcare companies across healthtech, life sciences, medtech, healthcare delivery, and climate health. The fund plans to invest between $7 million to $25 million per company over the next four years, focusing on businesses with proven clinical outcomes, scalable operations, and sustainable infrastructure models. “HealthKois will support healthcare enterprises addressing gaps in access, affordability, and quality,” said Charles Janssen. “With access to over 75% proprietary deal flow, we are positioned to deliver both financial returns and real-world health impact.” HealthKois will adopt a hands-on, founder-first approach, offering capital alongside strategic guidance, market expansion support, and governance planning. The firm’s team brings over 100 years of combined experience in clinical care, operations, and healthcare investing, and operates across Asia and Europe. HealthKois builds on the success of HealthQuad Funds I and II, which claims to have impacted over 90 million lives and serve more than 8 million patients annually.
View Source
Bernstein Ups Zomato’s Price Target To INR 120, Says Foodtech Raising The Profitability Bar
Inc42
·
1y ago
Medial
Bernstein, a brokerage firm, has raised its price target (PT) for Zomato stock to INR 120 from INR 100 after the foodtech company reported its first-ever profitable quarter in Q1 FY24. Bernstein believes Zomato can achieve long-term, high-teens growth in food delivery with improving contribution margins. The brokerage noted that Zomato's strong execution and profit performance have increased investor confidence. Equirus Securities also initiated coverage on Zomato with a 'long' rating and a PT of INR 135, citing Zomato's dominance in the food delivery space and its potential for robust sales growth.
View Source
Trackers
Active Indian VC’s
OG Capital
Email
With a hands-on approach, OG Capital aims to invest in over 20 promising...
Accel Partners
Email
Early and growth-stage investments in disruptive technology companies with...
Blume
Email
Early-stage venture capital firm investing in technology startups in India. Focus on...
Access All Trackers
Startup Showcase Winners
June 2025
Buddy
Helping your parents when you are miles away
BiteStop
The Pit Stop Your Cravings Deserve
Bloomer
The next generation E-commerce platform
Enter Ongoing Startup Showcase
Top Users
Trending News on Medial
Download the medial app to read full posts, comements and news.
Go to Medial App
Not Now
Know everything that’s happening in the startup ecosystem, first.
Enable Notifications?
No, thanks
Count me in